Sparkes Andrew H, Caney Sarah, Chalhoub Serge, Elliott Jonathan, Finch Natalie, Gajanayake Isuru, Langston Catherine, Lefebvre Hervé P, White Joanna, Quimby Jessica
International Cat Care/ISFM, UK
Vet Professionals, UK.
J Feline Med Surg. 2016 Mar;18(3):219-39. doi: 10.1177/1098612X16631234.
Chronic kidney disease (CKD) is one of the most commonly diagnosed diseases in older cats. In most cats, CKD is also a progressive disease and can be accompanied by a wide range of clinical and clinicopathological changes. These ISFM Consensus Guidelines have been developed by an independent panel of clinicians and academics to provide practical advice on the diagnosis and management of this complex disease.
Although CKD is a common clinical problem in cats, the manifestations of disease vary between individuals. Thus there is a need for careful and repeat evaluation of cats with CKD and adjustment of therapy according to individual needs. In addition to addressing problems arising from CKD and improving quality of life (QoL) for the patient, therapy may also target slowing the underlying progression of disease and hence prolonging life. While maintaining QoL is of paramount importance in our patients, this can be challenging when multiple therapies are indicated. In some cases it is necessary to prioritise therapy, given an understanding of what is likely to most benefit the individual patient.
In preparing these Guidelines, the Panel has carefully reviewed the existing published literature, and has also graded the quality of evidence for different interventions to help to provide practical recommendations on the therapeutic options for feline CKD. This is a field of veterinary medicine that has benefited from some excellent published clinical research and further research findings will undoubtedly modify the recommendations contained in these Guidelines in the future.
慢性肾病(CKD)是老年猫中最常被诊断出的疾病之一。在大多数猫中,CKD也是一种渐进性疾病,可能伴有广泛的临床和临床病理变化。这些国际猫科医学协会(ISFM)共识指南由一组独立的临床医生和学者制定,旨在为这种复杂疾病的诊断和管理提供实用建议。
虽然CKD是猫常见的临床问题,但疾病表现因个体而异。因此,需要对患有CKD的猫进行仔细且反复的评估,并根据个体需求调整治疗方案。除了解决CKD引发的问题并改善患者的生活质量(QoL)外,治疗还可能旨在减缓疾病的潜在进展,从而延长寿命。虽然维持生活质量对我们的患者至关重要,但当需要多种治疗时,这可能具有挑战性。在某些情况下,鉴于了解何种治疗最可能使个体患者受益,有必要对治疗进行优先排序。
在制定这些指南时,专家组仔细审查了现有的已发表文献,并对不同干预措施的证据质量进行了分级,以帮助就猫CKD的治疗选择提供实用建议。这是兽医学领域,已经从一些出色的已发表临床研究中受益,未来进一步的研究结果无疑将修改这些指南中的建议。